Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PHOSPHODIESTERASE | authKW | 550621 | 5% | 33% | 555 |
2 | ROLIPRAM | authKW | 419263 | 2% | 55% | 248 |
3 | PDE4 | authKW | 306188 | 1% | 73% | 138 |
4 | ROFLUMILAST | authKW | 191806 | 1% | 70% | 90 |
5 | PDE4 INHIBITOR | authKW | 183920 | 1% | 71% | 85 |
6 | CGMP | authKW | 180148 | 4% | 15% | 393 |
7 | PDE10A | authKW | 173813 | 1% | 89% | 64 |
8 | CAMP | authKW | 153093 | 6% | 9% | 582 |
9 | YC 1 | authKW | 144872 | 1% | 62% | 77 |
10 | AKAP | authKW | 142052 | 1% | 54% | 86 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 19699 | 38% | 0% | 3896 |
2 | Pharmacology & Pharmacy | 8727 | 19% | 0% | 1947 |
3 | Cell Biology | 5023 | 13% | 0% | 1344 |
4 | Chemistry, Medicinal | 2860 | 6% | 0% | 583 |
5 | Biophysics | 2319 | 6% | 0% | 664 |
6 | Cardiac & Cardiovascular System | 1423 | 6% | 0% | 608 |
7 | Peripheral Vascular Diseases | 1280 | 4% | 0% | 413 |
8 | Physiology | 1073 | 4% | 0% | 463 |
9 | Neurosciences | 1045 | 8% | 0% | 872 |
10 | Respiratory System | 372 | 2% | 0% | 227 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CELLULAR BIOCHEM SECT | 55429 | 0% | 55% | 33 |
2 | MOL PHARMACOL GRP | 24041 | 1% | 14% | 56 |
3 | PHARMACOL | 22573 | 11% | 1% | 1148 |
4 | PHARMACOMETR PHARMACOKINET | 21820 | 0% | 71% | 10 |
5 | DIPARTIMENTO BIOL PATOL MOL CELLULARE | 17198 | 0% | 43% | 13 |
6 | CARDIAC SIGNAL TRANSDUCT CELLULAR BIOL | 16291 | 0% | 67% | 8 |
7 | MED FAK MA N1 | 15278 | 0% | 100% | 5 |
8 | PULM CRIT CARE MED BRANCH | 14972 | 0% | 14% | 35 |
9 | PHARMAKOL TOXIKOL | 13543 | 1% | 6% | 78 |
10 | VOLLUM | 12910 | 1% | 6% | 73 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 20088 | 0% | 24% | 28 |
2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 16282 | 9% | 1% | 932 |
3 | CELLULAR SIGNALLING | 14241 | 1% | 3% | 146 |
4 | ADVANCES IN CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 14001 | 0% | 18% | 25 |
5 | ADVANCES IN SECOND MESSENGER AND PHOSPHOPROTEIN RESEARCH | 10059 | 0% | 12% | 28 |
6 | MOLECULAR PHARMACOLOGY | 8709 | 2% | 2% | 170 |
7 | JOURNAL OF CYCLIC NUCLEOTIDE RESEARCH | 7530 | 0% | 16% | 15 |
8 | BRITISH JOURNAL OF PHARMACOLOGY | 6235 | 2% | 1% | 196 |
9 | ADVANCES IN CYCLIC NUCLEOTIDE RESEARCH | 5759 | 0% | 17% | 11 |
10 | SECOND MESSENGERS AND PHOSPHOPROTEINS | 5076 | 0% | 17% | 10 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHOSPHODIESTERASE | 550621 | 5% | 33% | 555 | Search PHOSPHODIESTERASE | Search PHOSPHODIESTERASE |
2 | ROLIPRAM | 419263 | 2% | 55% | 248 | Search ROLIPRAM | Search ROLIPRAM |
3 | PDE4 | 306188 | 1% | 73% | 138 | Search PDE4 | Search PDE4 |
4 | ROFLUMILAST | 191806 | 1% | 70% | 90 | Search ROFLUMILAST | Search ROFLUMILAST |
5 | PDE4 INHIBITOR | 183920 | 1% | 71% | 85 | Search PDE4+INHIBITOR | Search PDE4+INHIBITOR |
6 | CGMP | 180148 | 4% | 15% | 393 | Search CGMP | Search CGMP |
7 | PDE10A | 173813 | 1% | 89% | 64 | Search PDE10A | Search PDE10A |
8 | CAMP | 153093 | 6% | 9% | 582 | Search CAMP | Search CAMP |
9 | YC 1 | 144872 | 1% | 62% | 77 | Search YC+1 | Search YC+1 |
10 | AKAP | 142052 | 1% | 54% | 86 | Search AKAP | Search AKAP |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |